Peptides: Legal and Regulatory Risks 503A Compounding Pharmacies Must Understand Is BPC157 Legal? WADA, FDA Status, and What You Need to Know The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 (20mg) Your Peptide Brand The FDA just announced a July advisory panel to review BPC 157, TB 500, and 5 more restricted peptides for legal compounding access. Full breakdown at the link in bio peptideacademy.io blog #peptides #BPC157 # The internet says BPC 157 is banned the FDA says something more nuanced. At Moonshot Medical in Park Ridge, IL, we provide honest, current guidance on peptide therapy through licensed compounding pharmacies.